Interferon alone versus interferon plus ribavirin in the treatment of patients with acute hepatitis C: A pilot study

被引：1
|
作者：
Santantonio, T [1 ]
Sinisi, E [1 ]
Guastadisegni, A [1 ]
Palumbo, E [1 ]
Pastore, G [1 ]
机构：
[1] Univ Bari, Clin Infect Dis, I-70121 Bari, Italy
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80456-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
456
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [41] Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C
    Khalili, M
    Denham, C
    Perrillo, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (05): : 1284 - 1289
  • [42] The effect of interferon plus ribavirin or interferon alone on the development of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis C
    Yang, HC
    Lai, MY
    Chen, PJ
    Kao, JH
    Chen, DS
    JOURNAL OF HEPATOLOGY, 2002, 36 : 250 - 250
  • [43] Interferon plus ribavirin (6 vs 12 months) in chronic hepatitis C patients non responders to interferon alone.
    Picciotto, A
    Torre, F
    Campo, N
    Giusto, R
    Brizzolara, R
    Sinelli, N
    Giudici-Cipriani, A
    Grasso, A
    De Conca, V
    Marenco, G
    Menardo, G
    Michetti, P
    HEPATOLOGY, 1999, 30 (04) : 263A - 263A
  • [44] Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C - A cochrane systematic review
    Simin, M
    Brok, F
    Stimac, D
    Gluud, C
    Gluud, LL
    HEPATOLOGY, 2005, 42 (04) : 666A - 666A
  • [45] A randomized 4-Arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone
    Saracco, G
    Ciancio, A
    Olivero, A
    Smedile, A
    Roffi, L
    Croce, G
    Colletta, C
    Cariti, G
    Andreoni, M
    Biglino, A
    Calleri, G
    Maggi, G
    Tappero, GF
    Orsi, PG
    Terreni, N
    Macor, A
    Di Napoli, A
    Rinaldi, E
    Ciccone, G
    Rizzetto, M
    HEPATOLOGY, 2001, 34 (01) : 133 - 138
  • [46] Interferon alpha-2b plus ribavirin for chronic hepatitis C in primary nonresponders to interferon alone
    Demir, K
    Kaymakoglu, S
    Dincer, D
    Tuncer, I
    Durakoglu, Z
    Karaca, C
    Besisik, F
    Cakaloglu, Y
    Okten, A
    JOURNAL OF HEPATOLOGY, 2001, 34 : 171 - 171
  • [47] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Rudolf E Stauber
    Harald Hofer
    Franz Hackl
    Kurt Schüze
    Christian Datz
    Karin Hegenbarth
    Wolfgang Jessner
    Petra Steindl-Munda
    Peter Ferenci
    Wiener Klinische Wochenschrift, 2004, 116 : 530 - 535
  • [48] Antifibrogenic effect of combination interferon plus ribavirin treatment in patients with chronic hepatitis C
    Guido, M
    De Franceschi, L
    Felder, M
    Zagni, I
    Capelli, P
    Corrocher, R
    Rugge, M
    Cavallini, G
    Fattovich, G
    JOURNAL OF HEPATOLOGY, 2005, 42 : 206 - 206
  • [49] A randomised 4-arm multicentre study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone
    Saracco, G
    Ciancio, A
    Olivero, A
    Smedile, A
    Roffi, L
    Croce, G
    Colletta, C
    Cariti, G
    Andreoni, M
    Biglino, A
    Calleri, G
    Maggi, G
    Tappero, GF
    Orsi, PG
    Terreni, N
    Macor, A
    Di Napoli, A
    Rinaldi, E
    Ciccone, G
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 3 - 3
  • [50] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    HEPATOLOGY, 2008, 48 (04) : 907A - 907A
12345